Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.

Abstract

Over time, it became evident that with the use of micronized progesterone and dydrogesterone prevention or treatment of pregnancy disorders such as threatened miscarriage, recurrent (habitual) miscarriage, preterm labor or preeclampsia appears to be possible. The results so far obtained will be delineated and concepts of prevention or treatment are suggested with the aim to further explore these pregnancy disorders either by prevention or treatment concepts to obtain not only benefits to the mother and the fetus, but furthermore this results in benefits for lifetime for the individual, for the family and last but not least for society.

• Authors: Adolf E Schindler
• Journal: Hormone molecular biology and clinical investigation (Horm Mol Biol Clin Investig) Vol. 27 Issue 2 Pg. 49-53 (Aug 01 2016) ISSN: 1868-1891 [Electronic] Germany
• PMID: 27662647 (Publication Type: Journal Article, Review)

Chemical References

• Progestins
• Dydrogesterone

Topics

• Abortion, Spontaneous (drug therapy, prevention & control)
• Dydrogesterone (administration & dosage, therapeutic use)
• Female
• Humans
• Pre-Eclampsia (drug therapy, prevention & control)
• Pregnancy
• Premature Birth (drug therapy, prevention & control)
• Progestins (administration & dosage, therapeutic use)